China Pharma Holdings, Inc.CPHINYSE
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-56.4%
5Y CAGR-28.2%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-56.4%/yr
vs +38.9%/yr prior
5Y CAGR
-28.2%/yr
Recent deceleration
Acceleration
-95.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 9.64 | +0.4% |
| 2023 | 9.60 | -70.0% |
| 2022 | 31.97 | -72.5% |
| 2021 | 116.23 | +22.1% |
| 2020 | 95.22 | +88.5% |
| 2019 | 50.51 | +3.7% |
| 2018 | 48.68 | +55.8% |
| 2017 | 31.25 | -20.0% |
| 2016 | 39.06 | +113.2% |
| 2015 | 18.32 | - |